MPZ

Chr 1ADAR

myelin protein zero

Also known as: CHM, CHN2, CMT1, CMT1B, CMT2I, CMT2J, CMT4E, CMTDI3

This gene is specifically expressed in Schwann cells of the peripheral nervous system and encodes a type I transmembrane glycoprotein that is a major structural protein of the peripheral myelin sheath. The encoded protein contains a large hydrophobic extracellular domain and a smaller basic intracellular domain, which are essential for the formation and stabilization of the multilamellar structure of the compact myelin. Mutations in this gene are associated with autosomal dominant form of Charcot-Marie-Tooth disease type 1 (CMT1B) and other polyneuropathies, such as Dejerine-Sottas syndrome (DSS) and congenital hypomyelinating neuropathy (CHN). A recent study showed that two isoforms are produced from the same mRNA by use of alternative in-frame translation termination codons via a stop codon readthrough mechanism. [provided by RefSeq, Oct 2015]

Primary Disease Associations & Inheritance

Charcot-Marie-Tooth disease, dominant intermediate DMIM #607791
AD
Charcot-Marie-Tooth disease, type 1BMIM #118200
AD
Charcot-Marie-Tooth disease, type 2IMIM #607677
AD
Charcot-Marie-Tooth disease, type 2JMIM #607736
AD
Dejerine-Sottas diseaseMIM #145900
ADAR
Hypomyelinating neuropathy, congenital, 2MIM #618184
AD
Roussy-Levy syndromeMIM #180800
AD
UniProtAdie pupil
UniProtDejerine-Sottas syndrome
549
ClinVar variants
162
Pathogenic / LP
0.27
pLI score
0
Active trials
Clinical SummaryMPZ
🧬
Gene-Disease Validity (ClinGen)
Charcot-Marie-Tooth disease · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.25) despite low pLI — interpret in context.
📋
ClinVar Variants
162 Pathogenic / Likely Pathogenic· 240 VUS of 549 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.64LOEUF
pLI 0.272
Z-score 2.43
OE 0.25 (0.110.64)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.99Z-score
OE missense 0.77 (0.660.90)
109 obs / 142.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.25 (0.110.64)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.77 (0.660.90)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.82
01.21.6
LoF obs/exp: 3 / 12.2Missense obs/exp: 109 / 142.1Syn Z: 1.08

ClinVar Variant Classifications

549 submitted variants in ClinVar

Classification Summary

Pathogenic88
Likely Pathogenic74
VUS240
Likely Benign97
Benign7
Conflicting43
88
Pathogenic
74
Likely Pathogenic
240
VUS
97
Likely Benign
7
Benign
43
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
29
28
30
1
88
Likely Pathogenic
21
39
12
2
74
VUS
6
188
39
7
240
Likely Benign
0
4
35
58
97
Benign
0
0
6
1
7
Conflicting
43
Total5625912269549

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MPZ · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

MPZ-related neuropathy, congenital hypomyelinating

definitive
ADUndeterminedUncertain
Dev. Disorders
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

MYELIN PROTEIN ZERO; MPZ
MIM #159440 · *

Charcot-Marie-Tooth disease, dominant intermediate D

MIM #607791

Molecular basis of disorder known

Autosomal dominant

Charcot-Marie-Tooth disease, type 1B

MIM #118200

Molecular basis of disorder known

Autosomal dominant

Charcot-Marie-Tooth disease, type 2I

MIM #607677

Molecular basis of disorder known

Autosomal dominant

Charcot-Marie-Tooth disease, type 2J

MIM #607736

Molecular basis of disorder known

Autosomal dominant

Dejerine-Sottas disease

MIM #145900

Molecular basis of disorder known

Autosomal dominantAutosomal recessive

Hypomyelinating neuropathy, congenital, 2

MIM #618184

Molecular basis of disorder known

Autosomal dominant

Roussy-Levy syndrome

MIM #180800

Molecular basis of disorder known

Autosomal dominant
📖
GeneReview available — MPZ
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →